Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Endometriosis is a chronic and debilitating condition affecting at least 10%—more than 200 million—of women and girls of reproductive age worldwide, severely impacting their quality of life and overall well-being. Characterized by the abnormal growth of endometrial tissue outside the uterus, Endometriosis can cause a range of distressing symptoms, including intense pelvic pain, painful intercourse, menstrual irregularities, and infertility.
Increasing awareness, improved diagnostic techniques, and the prevalence of the condition have given rise to the growing demand for safe and effective therapies in an underserved market—with a potential global annual market worth of $180 billion.
Gynica is owned by Asana Bio Group, a holding company specializing in life sciences innovations.